Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment

Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment

While topical corticosteroid (TCS) treatment is widely used for many skin diseases, it can trigger adverse side effects, and some of such effects can last for a long time after stopping the treatment. However, molecular changes induced by TCS treatment remain largely unexplored, although transient c...

Full description

Bibliographic Details
Main Authors: Yongsu Choi, Masaki Takasugi, Kazuaki Takemura, Yuya Yoshida, Tomonori Kamiya, Jun Adachi, Daisuke Tsuruta, Naoko Ohtani
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomolecules
Subjects:
topical corticosteroids (TCS)
fluocinolone acetonide (FA)
transcriptomics
proteomics
Online Access:https://www.mdpi.com/2218-273X/12/12/1822

Internet

https://www.mdpi.com/2218-273X/12/12/1822

Similar Items